Cisplatina pro Anti-cancri curatione
Productumnomen | Cisplatin |
Synonyma | cis-Diaminedichloroplatinum(II) |
CAS Non. | 15663-27-1 |
Aspectus | Flavo vel aurantiaco flavo crystallis pulveris |
Formulae hypotheticae | Cl2H6N2Pt |
M. Pondus | 300.05 |
Consuetudinem | Pharmaceutical Grade vel Research proposito |
stipare | Quod per petitio tua |
Repono | Serva in stricta, levis vasis repugnans in loco frigido |
Cisplatin CAS;15663-27-1 | ||
ITEMS | SIGNA | Effectus |
Aspectus | Flavo vel aurantiaco flavo crystallis pulveris | Yellow crystallis pulveris |
Spectrum | HPLCIR TLC * | ObsequiturObsequitur Obsequitur |
UV Puritatis Ratio | ≥4.5 | 5.2 |
Terminus trichloroammin-eplatinatus | ≤1.0% | 0.01% |
Terminus transplatin | ≤2.0% | ND |
Platinum content | 64.42%~ 65.22% | 65.06% |
Aquae | ≤1.0% | 0.10% |
Assay(Ratio in anhydrous basis) | 98.0%~102.0% | 99.8% |
Bacterial Endotoxins | ≤2.0EU/mg | Obsequitur |
Conclusio cedit USP vexillum. |
Company Information
√ Procuratio accumsan plena experientia in technicis et technicis peritissimis sectatoribus; √ Quality is always our top consideration, Strict QC system; √ 11 annos periti quadrigis venditio educendi; √ Independentes R&D lab; √ Duae officinae GMP terminus signati longi sunt; √ Divites copiarum otiosorum officinarum copia pro project nativus; √ High Efficiency working team with consistent path.Epistulam tuam hic scribe et mitte nobis